RIYAD: Saudi Arabia’s Food and Drug Authority (SFDA) has warned that a newly implemented value added tax should not be applied to human drugs, imported vitamins and medical devices and products. The authority’s awareness and information executive director, Dr Abdulrahman Al-Sultan, said it was closely monitoring the commitment of companies and pharmacies to not charge the 5 per cent tax on registered products.
Consumers have been instructed to report any violations to the General Authority of Zakat and Tax. The announcement that medical products and devices would not be taxed under the new regime on January 1 came last month.
